"An AIDS Rally Seeks Faster Testing of Drugs"

Important note: Information in this article was accurate in 1990. The state of the art may have changed since the publication date.

"An AIDS Rally Seeks Faster Testing of Drugs"

Philadelphia Inquirer (12/20/90), P. 3B
Copeland, Larry

Abstract: Activists groups around the country joined yesterday in a protest to demand faster approval Food and Drug Administration (FDA) approval of ddI and ddC, two experimental AIDS drugs shown to be effective in combination with AZT. In Philadelphia, one of six cities across the nation in which ACT UP, Project Inform, other organizations held demonstrations, members of the city's AIDS office and a Hahnemann University Hospital physician joined the protest, chanting, "Ten years! A billion dollars! One drug! Big deal!" Coleman Terrell, a member of ACT UP, said HIV evolves strains resistant to AZT within six to 18 months of treatment, making early treatment with combination therapy using ddI or ddC crucial. FDA spokesperson Brad Stone said that neither of the companies testing the experimental drugs had applied for approval, and that the FDA "can't review critical data until it's submitted." Meanwhile, in Philadelphia alone, 40,000 people have tested positive for HIV, a caseload certain to overload the city's hospital system, according to the city's AIDS office.

901220
AD901515

Copyright © 1990 - Information, Inc., Bethesda, MD. The CDC National Center for HIV, STD and TB Prevention provides the following information as a public service only. Providing synopses of key scientific articles and lay media reports on HIV/AIDS, other sexually transmitted diseases and tuberculosis does not constitute CDC endorsement. This daily update also includes information from CDC and other government agencies, such as background on Morbidity and Mortality Weekly Report (MMWR) articles, fact sheets, press releases and announcements. Reproduction of this text is encouraged; however, copies may not be sold, and the CDC HIV/STD/TB Prevention News Update should be cited as the source of the information. Contact the sources of the articles abstracted below for full texts of the articles.

AEGiS is a 501(c)3, not-for-profit, tax-exempt, educational corporation. AEGiS is made possible through unrestricted funding from Boehringer Ingelheim, Bridgestone/Firestone Charitable Trust, Elton John AIDS Foundation, the National Library of Medicine, AIDS Walk of Orange County, and donations from users like you.

Always watch for outdated information. This article first appeared in 1990. This material is designed to support, not replace, the relationship that exists between you and your doctor.

AEGiS presents published material, reprinted with permission and neither endorses nor opposes any material. All information contained on this website, including information relating to health conditions, products, and treatments, is for informational purposes only. It is often presented in summary or aggregate form. It is not meant to be a substitute for the advice provided by your own physician or other medical professionals. Always discuss treatment options with a doctor who specializes in treating HIV.

Copyright ©1980, 1990. AEGiS. All materials appearing on AEGiS are protected by copyright as a collective work or compilation under U.S. copyright and other laws and are the property of AEGiS, or the party credited as the provider of the content.